Integra Lifesciences Holdings (IART) Other Non-Current Assets (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Other Non-Current Assets data on file, last reported at $35.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 34.28% year-over-year to $35.0 million; the trailing twelve-month figure through Mar 2026 stood at $35.0 million (down 34.28% YoY), and the FY2025 full-year result was $37.9 million, down 43.05% from the prior year.
• Other Non-Current Assets slipped to $35.0 million in Q1 2026, from $37.9 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $77.9 million in Q3 2023 to a low of $29.5 million in Q1 2022.
• A 5-year average of $55.7 million and a median of $56.2 million in 2023 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets soared 247.87% in 2022 and plunged 43.05% in 2025, its largest moves.
• Tracing IART's Other Non-Current Assets over 5 years: stood at $57.2 million in 2022, then gained by 1.76% to $58.2 million in 2023, then rose by 14.3% to $66.5 million in 2024, then sank by 43.05% to $37.9 million in 2025, then dropped by 7.71% to $35.0 million in 2026.
• Business Quant data shows IART's Other Non-Current Assets at $35.0 million in Q1 2026, $37.9 million in Q4 2025, and $42.2 million in Q3 2025.